Every lawsuit that involves a drug, in federal court and in state court, the courts put together a schedule on how they want the case to roll out. And typically that schedule, goes in the same order every time. It’s just a matter of how long each step in the road takes. So discovery process, which is the process by which the plaintiffs are able to get information from the manufacturers about the development of the drug, the regulation of the drug, their interaction with the FDA, injuries they either knew or didn’t know, were going to happen and may have hid that information or failed to warn about it. All of those types of things are fertile ground for plaintiffs’ attorneys when it comes to the discovery process. That happens almost throughout the entirety of a lawsuit. Kind of side by side with that, which is no less important than, than the discovery process, is, how experts are utilized, both by the defense and both by the plaintiffs. And process takes place over a period of months and months and months, where depositions are taken of the experts that the plaintiffs are putting up, depositions are taken of the experts the defendants are putting up, and then briefs are written, presented to the court, and the court is asked to make a decision on which experts get to testify, and what they get to testify about. And that is probably the most important part of any drug litigation, and that piece of the puzzle in the Ozempic case is currently ongoing.